Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan

Gut

Volumn 52, Issue 11, 2003, Pages 1630-1637

  Imamura, T ^a   Yokosuka, O ^a   Kurihara, T ^a   Kanda, T ^a   Fukai, K ^a   Imazeki, F ^a   Saisho, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS CORE; VIRUS GENE; VIRUS MUTATION;

ACUTE DISEASE; ADULT; BASE SEQUENCE; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; JAPAN; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS (GENETICS);

EID: 0242298194     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.11.1630     Document Type: Article

References (45)

1. Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69:2575-83.
2. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-503.
3. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81(Pt 1):67-74.
4. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus - large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285-93.
5. Rodriguez-Frias F, Buti M, Jardi R, et al. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995;22:1641-7.
6. Odemuyiwa SO, Mulders MN, Oyedele Ol, et al. Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 2001;65:463-9.
7. Blitz L, Pujol FH, Swenson PD, et al. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol 1998;36:648-51.
8. Arauz-Ruiz P, Norder H, Visona KA, et al. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant. J Med Virol 1997;51:305-12.
9. Ding X, Mizokami M, Yao G, et al. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001;44:43-7.
10. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-4.
11. Grandjacques C, Pradat P, Stuyver L, et al. Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 2000;33:430-9.
12. Orito E, Mizokami M, Sakugawa H, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001;33:218-23.
13. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9.
14. Lindh M, Hannoun C, Dhillon AP, et al. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 1999;179:775-82.
15. Kao JH, Wu NH, Chen PJ, et al. Hepatitis B genotypes and the response to Interferon therapy. J Hepatol 2000;33:998-1002.
16. Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699-704.
17. Ehata T, Omata M, Chuang WL, et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993;91:1206-13.
18. Kojima M, Shimizu M, Tsuchimochi T, et al. Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants. Vox Song 1991;60:34-9.
19. Hasegawa K, Huang JK, Wands JR, et al. Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan. Virology 1991;185:460-3.
20. Aye TT, Uchida T, Becker SO, et al. Variations of hepatitis B virus precore/ core gene sequence in acute and fulminant hepatitis B. Dig Dis Sci 1994;39:1281-7.
21. Chu CM, Yeh CT, Chiu CT, et al. Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic. J Clin Microbiol 1996;34:1815-18.
22. Terazawa S, Kojima M, Yamanaka T, et al. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res 1991;29:5-9.
23. Yotsumoto S, Kojima M, Shoji I, et al. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. Hepatology 1992;16:31-5.
24. Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995;122:241-8.
25. Laskus T, Persing DH, Nowicki MJ, et al. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993;105:1173-8.
26. Liang TJ, Hasegawa K, Munoz SJ, et al. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest 1994;93:550-5.
27. Feray C, Gigou M, Samuel D, et al. Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol 1993;18:119-22.
28. Laskus T, Rakela J, Nowicki MJ, et al. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995;109:1618-23.
29. Karayiannis P, Alexopoulou A, Hadziyannis S, et al. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 1995;22:1628-34.
30. Sterneck M, Kalinina T, Gunther S, et al. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998;28:1390-7.
31. Honda A, Yokosuka O, Suzuki K, et al. Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection. J Med Virol 2000;62:167-76.
32. Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97-112.
33. Mizakami M, Nakano T, Orito E, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999;450:66-71.
34. Yokosuka O, Omata M, Hosoda K, et al. Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. Gastroenterology 1991;100:175-81.
35. Fujie H, Moriya K, Shintani Y, et al. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology 2001;120:1564-5.
36. Kozik CA, Vaughn DW, Snitbhan R, et al. Hepatitis B virus infection in Thai children. Trop Med Int Health 2000;5:633-9.
37. Penna A, Chisari FV, Bertoletti A, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991;174:1565-70.
38. Bertoletti A, Ferrari C, Fiaccadori F, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 1991;88:10445-9.
39. Nayersina R, Fowler P, Guilhot S, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993;150:4659-71.
40. Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-58.
41. Bertoletti A, Chisari FV, Penna A, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 1993;67:2376-80.
42. Missale G, Redeker A, Person J, et al. HLA-A31-and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993;177:751-62.
43. Jin Y, Shih WK, Berkower I. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med 1988;168:293-306.
44. Li JS, Tong SP, Wen YM, et al. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993;67:5402-10.
45. Takahashi K, Ohta Y, Kanai K, et al. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol 1999;144:1299-308.